Medicine

Green Active, a UK-based CBD company, announced a donation program to help the family of an eight-year-old cannabis patient pay for his medicine as the NHS refuses to write a prescription providing it to the family for free.

The UK’s National Health Service has only issued three prescriptions for medical cannabis oil since it was legalized two years ago, according to medical cannabis advocacy group End Our Pain.

A study presented at the North American Menopause Society reported that more women have used cannabis to manage symptoms of menopause than a more traditional hormone therapy.

A recent study by the Journal of the American Geriatrics Society suggests that seniors are using cannabis more frequently in the treatment of common ailments like pain, arthritis, and anxiety.

Billy Caldwell, who became the figurehead of medical cannabis policy changes in the UK, will receive his first bottle of cannabis-derived medicine two years after the necessary reforms took place.

A recent study found that patients experienced reduced OCD symptoms after inhaling cannabis products.

A recent study found that 82 percent of migraine patients say that medical cannabis has provided them relief from migraine pain.

Medical cannabis patients in New Jersey can now receive doctor recommendations for the program online through the use of telemedicine services.

The FDA has expanded the label of Epidiolex, the first CBD-based medication approved by the federal agency, to treat seizures resulting from tuberous sclerosis complex.

Thailand is allowing hospitals to produce traditional medicines that contain cannabis, as long as an expert in traditional Thai medicines is on duty to prepare them.

Despite legalizing more than 18 months ago, the UK National Health Services has yet to issue a single government-funded prescription for medical cannabis.

Dr. Thomas Macsay is a naturopath and medical advisor for Neurogan, a health-minded CBD company with Scandinavian roots.

Dr. Lester Grinspoon — famed cannabis doctor, advocate, and author — passed away last week at 92.

The U.S. Defense Advanced Research Projects Agency is funding a medical health study into the therapeutic use of psychedelics such as ketamine and psilocybin.

Science suggests that there is a relationship between the endocannabinoid system and the immune system, but researchers are still working to fully understand how and why.

The federal government is withholding $3.3 million slated for children’s mental health programs in Maine because the state allows students to be medical cannabis patients.

A recent study published in Frontiers in Psychology suggests there is no evidence suggesting that just prenatal cannabis exposure can lead to significant cognitive impairments.

Australian researchers have uncovered evidence that a cannabis-based treatment could be effective against chronic insomnia.

There are many conflicting reports about the safety of cannabis use for pregnant women. Here’s what we know:

Canadian cannabis healthcare technology company Cannalogue has applied to conduct clinical trials investigating potential cannabis-based treatments for COVID-19.

Researchers at the University of Southern Denmark have uncovered evidence that CBD can help antibiotics in the fight against antibiotic-resistant bacteria.

A study published last month shows that cannabis could be an effective and safer alternative treatment for fibromyalgia symptoms.

Today marks the opening of Utah’s very first medical cannabis dispensaries.

Researchers at McMaster University in Canada have discovered that cannabigerol (CBG) is capable of defeating MRSA, an infection infamously resistant to many traditional antibiotics.